ArticleBiomedical reports2026
Tricellulin regulates the tight junctions and cytoskeleton of pancreatic acinar cells through the NF-κB pathway in hypertriglyceridemic acute pancreatitis.
Article in Biomedical reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertriglyceridemic acute pancreatitis (HTGAP) is a clinical emergency. Tight junctions (TJs) and the cytoskeleton are essential for cell-cell junctions and cell survival, and although tricellulin is a key protein regulating cell junctions, its role in regulating TJ proteins and the cytoskeleton in pancreatic acinar cells in HTGAP is not currently clear. In the present study, 24 female hamsters were assigned to the control, hypertriglyceridemia (HTG), HTGAP and HTGAP + SC75741 groups. HTG was induced by a high-fat diet and HTGAP was established by retrograde sodium taurocholate injection. Serum triglyceride levels, pancreatic histopathological changes, and pancreatic expression of tricellulin, claudin-1 and NF-κB p65 were assessed. Furthermore, AR42J cell models with tricellulin overexpression and knockdown were cultured under HTG conditions, and protein levels were semi-quantified by western blotting. F-actin organization was assessed by immunofluorescence staining and intercellular morphology was examined by scanning electron microscopy. The results revealed that tricellulin expression was decreased and p65 expression was increased under hypertriglyceridemic conditions, whereas pancreatic histopathological injury was not significantly increased in the HTG group. The HTGAP group showed significantly more severe pancreatic injury than the control and HTG groups, accompanied by significantly decreased tricellulin and claudin-1 expression, and significantly increased p65 expression. After SC75741 (an inhibitor of the NF-κB signaling pathway) treatment, pancreatic injury and p65 expression were significantly decreased, whereas tricellulin and claudin-1 showed only partial recovery. In AR42J cells, tricellulin overexpression was associated with increased claudin-1 expression, reduced NF-κB activation, improved F-actin organization and better-preserved intercellular morphology, whereas tricellulin knockdown exhibited the opposite pattern. In conclusion, hypertriglyceridemic conditions were associated with impaired TJ integrity and cytoskeletal disorganization in pancreatic acinar cells, accompanied by reduced tricellulin expression and increased NF-κB activation. These findings suggest that tricellulin may contribute to HTGAP-related junctional and cytoskeletal injury, potentially involving NF-κB signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.